COMMUNIQUÉS West-GlobeNewswire

Standard Dental Labs Inc.: Investor Education Series — Part 2
12/11/2025
From Workbench to Workflow: Digitizing Craftsmanship at Scale Digitizing craftsmanship—at scale. ORLANDO, Fla., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Standard Dental Labs Inc. (OTCQB: TUTH) today published Part 2 of its [...]
Mainz Biomed Showcases Innovative Cancer Detection Solutions at MEDICA 2025
12/11/2025
BERKELEY, Calif. and MAINZ, Germany, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of [...]
Evaxion announce 2026 financial calendar
12/11/2025
COPENHAGEN, Denmark, November 12, 2025 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, announces its financial calendar for 2026 as [...]
Picard to Attend the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum November 20, 2025, in New York City
12/11/2025
TUCSON, Ariz., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first total artificial heart approved [...]
Beacon Therapeutics to Participate in the Jefferies Global Healthcare Conference
12/11/2025
LONDON and CAMBRIDGE, Mass., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Beacon Therapeutics Holdings Limited (‘Beacon Therapeutics’ or ‘the Company’), a leading clinical-stage biotechnology company with a mission to save and [...]
LB Pharmaceuticals Appoints Kaya Pai Panandiker as Chief Commercial Officer
12/11/2025
NEW YORK, Nov. 12, 2025 (GLOBE NEWSWIRE) -- LB Pharmaceuticals, Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a clinical-stage biopharmaceutical company developing novel therapies for schizophrenia, [...]
Essity Brand, JOBST®, Teams Up with Toronto Raptors to Prove that “Not All Armour is Made of Steel”
12/11/2025
TORONTO, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Essity brand, JOBST®, a global leader in compression solutions, is thrilled to announce a strategic new partnership with the Toronto Raptors , Canada’s premier basketball team [...]
Essity et sa marque JOBST® font équipe avec les Raptors de Toronto pour prouver que « Les armures ne sont pas toutes faites d'acier »
12/11/2025
TORONTO, 12 nov. 2025 (GLOBE NEWSWIRE) -- Essity, chef de file mondial des solutions de compression, et sa marque JOBST® sont ravis d'annoncer un nouveau partenariat stratégique avec les Raptors de Toronto , l'équipe de [...]
Collegium to Participate in Upcoming Investor Conferences
12/11/2025
STOUGHTON, Mass., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that its management will participate in the following investor conferences: Jefferies London Healthcare [...]
Elite Dentistry Launches Comprehensive Laser Dentistry Services, Building on Strong Community Roots in Rancho Santa Margarita
12/11/2025
Rancho Santa Margarita, CA, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Elite Dentistry, a modern tech-forward dental practice led by Dr. Mehran Rastegar-Lari, is proud to announce the official launch of its comprehensive laser [...]
From Parliament Hill to Capitol Hill to the Brussels Bubble — Who’s the Cutest Pet?
12/11/2025
Global Cutest Pets Showdown Unites the Animal Health Industry in a Friendly (and Furry) Competition OTTAWA, Ontario, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Three national and regional animal health associations are joining [...]
Seoul National University Hospital Showcases Korea’s Next-Generation Medical Technologies at MEDICA 2025
12/11/2025
Smart Ophthalmic, Dementia Care, and AI Musculoskeletal Solutions Take the Global Stage SEOUL, South Korea, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Seoul National University Hospital (SNUH) is set to lead Korea’s [...]
DBV Technologies Announces Last Patient Visit Completed in VITESSE Phase 3 Clinical Trial of VIASKIN® Peanut Patch in Peanut Allergic Children Aged 4-7 Years
12/11/2025
Châtillon, France, November 11, 2025 DBV Technologies Announces Last Patient Visit Completed in VITESSE Phase 3 Clinical Trial of VIASKIN ® Peanut Patch in Peanut Allergic Children Aged 4-7 Years Company remains on [...]
DBV Technologies annonce la dernière visite du dernier patient dans l'essai clinique de phase 3 VITESSE du patch VIASKIN® Peanut chez les enfants âgés de 4 à 7 ans allergiques aux arachides
12/11/2025
Châtillon, France, 12 novembre, 2025 DBV Technologies annonce la dernière visite du dernier patient dans l'essai clinique de phase 3 VITESSE du patch VIASKIN® Peanut chez les enfants âgés de 4 à 7 ans allergiques aux [...]
Cogent Biosciences Announces Pricing of Concurrent Public Offerings of Common Stock and 1.625% Convertible Senior Notes Due 2031
12/11/2025
WALTHAM, Mass. and BOULDER, Colo., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (“Cogent”) (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases [...]
Centessa Pharmaceuticals Announces Pricing of $250,000,000 Public Offering of American Depositary Shares
12/11/2025
BOSTON and LONDON, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company, today announced the pricing of an underwritten public offering of 11,627,907 [...]
BPGbio Appoints John Dvor as Executive Vice President, Corporate Development
12/11/2025
Veteran life sciences executive and dealmaker to drive strategic partnerships, capital formation, and corporate growth initiatives BOSTON, Nov. 11, 2025 (GLOBE NEWSWIRE) -- BPGbio, Inc., a biology-first, AI-powered, [...]
Eledon Pharmaceuticals Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants
11/11/2025
IRVINE, Calif., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), today announced that it has commenced an underwritten public offering of shares of its common stock and, in lieu [...]
COSCIENS Biopharma Inc. Reports Third Quarter 2025 Financial Results and Provides Strategic Initiatives Update
11/11/2025
COSCIENS voluntarily delists from Nasdaq, while retaining the Company’s listing on the TSX COSCIENS restructuring results in significantly lower cash outflow with operating expenses down 59% vs. Q3 2024. TORONTO, [...]

Pages